Drug Profile
Human fibrinogen - China Biologic Products
Latest Information Update: 10 Dec 2021
Price :
$50
*
At a glance
- Originator China Biologic Products
- Class Acute-phase proteins; Antihaemorrhagics; Blood coagulation factors; Coagulants
- Mechanism of Action Fibrinogen replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Afibrinogenaemia